Rocaltrol 0.25 mcg (Calcitriol) Migraine Abortive Therapy Food and Drug Administration for

Food and Drug Administration for use alongside a healthy diet and exercise to improve lipid profiles in patients at risk for cardiovascular events

Abrupt discontinuation is not advised

a pediatric formulation (e

the drug reduces the urge to move the legs during periods of inactivity

Rocaltrol 0.25 mcg (Calcitriol) Migraine Abortive Therapy Food and Drug Administration forRocaltrol 0. 25 mcg (Calcitriol) Product Overview Rocaltrol 0. 25 mcg (Calcitriol) is a prescription medication that belongs to the class of vitamin D analogues. It is formulated as soft gelatin capsules, each containing 0. 25 micrograms of the active ingredient calcitriol, the biologically active form of vitamin D. Manufactured by Abbott India Pvt Ltd, this product is specifically indicated for patients who need to enhance the mineralization of bone